31 Mar 2010 12:24
Immunodiagnostic Systems Holdings plc
('the Company')
31 March 2010
Total Voting Rights
In conformity with the FSA's Disclosure and Transparency Rules, the Company notifies the market of the following:
As at the date of this announcement, the Company's issued share capital consists of 27,854,566 ordinary shares with a nominal value of 2 pence each ('Ordinary Shares'), with voting rights.
The Company does not hold any Ordinary Shares in Treasury.
The above figure of 27,854,566 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
For further information:
Immunodiagnostic Systems Holdings plc Tel: 0191 519 0660
Roger Duggan, CEO
Paul Hailes, Finance Director
Brewin Dolphin Investment Banking Tel: 0845 213 4730
Andrew Emmott
Sean Wyndham-Quin